CR9578A - Inhibidores de la adenilato ciclasa soluble - Google Patents

Inhibidores de la adenilato ciclasa soluble

Info

Publication number
CR9578A
CR9578A CR9578A CR9578A CR9578A CR 9578 A CR9578 A CR 9578A CR 9578 A CR9578 A CR 9578A CR 9578 A CR9578 A CR 9578A CR 9578 A CR9578 A CR 9578A
Authority
CR
Costa Rica
Prior art keywords
adenylate
cycling
inhibitors
soluble
medicine
Prior art date
Application number
CR9578A
Other languages
English (en)
Inventor
Bernd Buchmann
Duy Nguyen
Martin Fritsch
Bernd Menzenbach
Ulf Boemer
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of CR9578A publication Critical patent/CR9578A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

La invencion se relaciona con compuestos de la formula general (I), y con su preparacion y su uso como medicamento.
CR9578A 2005-06-08 2007-12-07 Inhibidores de la adenilato ciclasa soluble CR9578A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005027274A DE102005027274A1 (de) 2005-06-08 2005-06-08 Inhibitoren der löslichen Adenylatzyklase

Publications (1)

Publication Number Publication Date
CR9578A true CR9578A (es) 2008-03-06

Family

ID=37398540

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9578A CR9578A (es) 2005-06-08 2007-12-07 Inhibidores de la adenilato ciclasa soluble

Country Status (23)

Country Link
EP (1) EP1888058B1 (es)
JP (1) JP2008542422A (es)
KR (1) KR20080016617A (es)
CN (1) CN101193631A (es)
AR (1) AR054378A1 (es)
AT (1) ATE431736T1 (es)
AU (1) AU2006256857A1 (es)
BR (1) BRPI0610934A2 (es)
CA (1) CA2606692A1 (es)
CR (1) CR9578A (es)
DE (2) DE102005027274A1 (es)
DO (1) DOP2006000130A (es)
EA (1) EA200702590A1 (es)
EC (1) ECSP078024A (es)
GT (1) GT200600244A (es)
IL (1) IL186914A0 (es)
MX (1) MX2007015493A (es)
NO (1) NO20080104L (es)
PE (1) PE20061488A1 (es)
TW (1) TW200716090A (es)
UY (1) UY29583A1 (es)
WO (1) WO2006131398A2 (es)
ZA (1) ZA200800153B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006014319B4 (de) * 2006-03-23 2009-01-08 Bayer Schering Pharma Aktiengesellschaft Inhibitoren der löslichen Adenylatzyklase
EP2036906A1 (de) * 2007-09-05 2009-03-18 Bayer Schering Pharma Aktiengesellschaft Azaindole als Inhibitoren der löslichen Adenylatzyklase

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2635776B1 (fr) * 1988-09-01 1993-06-11 Rhone Poulenc Agrochimie Derives amides, procede pour leur fabrication et compositions fongicides les contenant
AU2001287060A1 (en) * 2000-09-05 2002-03-22 University Of Virginia Patent Foundation Human soluble testicular adenylyl cyclase
AU2002307839B2 (en) * 2001-06-28 2006-03-16 Zoetis P Llc Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (MTP) and/or apolipoprotein B (Apo B) secretion
EP1429765A2 (en) * 2001-09-14 2004-06-23 Methylgene, Inc. Inhibitors of histone deacetylase
UA79504C2 (en) * 2002-11-07 2007-06-25 Organon Nv Indols for treating diseases associated with androgen receptors
EP1663242B1 (en) * 2003-08-07 2011-04-27 Rigel Pharmaceuticals, Inc. 2,4-pyrimidinediamine compounds and uses as anti-proliferative agents
EP1677731A4 (en) * 2003-10-09 2009-05-06 Aton Pharma Inc THIOPHENE AND BENZOTHIOPHENE DERIVATIVES OF HYDROXAMIC ACID
WO2005070419A1 (en) * 2004-01-21 2005-08-04 Cornell Research Foundation, Inc. Chemical inhibitors of soluble adenylyl cyclase (sac)
JP5319113B2 (ja) * 2004-03-26 2013-10-16 メチルジーン インコーポレイテッド ヒストンデアセチラーゼの阻害剤
DE102004047272A1 (de) * 2004-09-24 2006-04-06 Schering Ag Inhibitoren der löslichen Adenylatzyklase

Also Published As

Publication number Publication date
MX2007015493A (es) 2008-02-22
GT200600244A (es) 2007-01-23
PE20061488A1 (es) 2007-02-03
BRPI0610934A2 (pt) 2010-08-03
AR054378A1 (es) 2007-06-20
ATE431736T1 (de) 2009-06-15
KR20080016617A (ko) 2008-02-21
DE602006006908D1 (de) 2009-07-02
ECSP078024A (es) 2008-01-23
WO2006131398A3 (en) 2007-04-19
CN101193631A (zh) 2008-06-04
JP2008542422A (ja) 2008-11-27
EA200702590A1 (ru) 2008-06-30
AU2006256857A1 (en) 2006-12-14
UY29583A1 (es) 2007-01-31
DE102005027274A1 (de) 2006-12-14
DOP2006000130A (es) 2006-11-30
EP1888058A2 (en) 2008-02-20
ZA200800153B (en) 2009-03-25
CA2606692A1 (en) 2006-12-14
NO20080104L (no) 2008-03-03
IL186914A0 (en) 2008-02-09
TW200716090A (en) 2007-05-01
EP1888058B1 (en) 2009-05-20
WO2006131398A2 (en) 2006-12-14

Similar Documents

Publication Publication Date Title
CR11241A (es) Compuestos de pirazol y su uso como inhibidores de raf
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
PA8657801A1 (es) Aminalcoholes triciclicos, procedimientos para su preparacion
NO20090295L (no) Substituerte heteroarylderivater
EA201070519A1 (ru) Соединения тропана
ECSP077271A (es) Derivados de pirimidina
EA200870116A1 (ru) Бициклические гетероарильные соединения
EA201170772A1 (ru) Органические соединения
BRPI0915084B8 (pt) composto, e, composição farmacêutica
ECSP077259A (es) Derivados de pirimidina
DE602006009789D1 (de) Acetylenderivate
EA201000614A1 (ru) Производные пурина как лиганды аденозинового рецептора а
BRPI0513149A (pt) uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituìdas no tratamento de náuseas e vÈmito
UY28917A1 (es) Derivados de tetrahidroisoquinolilsulfonamidas composiciones farmaceuticas y su uso terapeutico
UY31016A1 (es) Nuevos compuestos heterociclicos nitrogenados, su preparacion y su utilizacion como medicamentos antibacterianos
ATE417849T1 (de) Pyrazoloä4,3-düpyrimidine
UY29859A1 (es) Derivados de 1-amino-isiquinolina,su preparación y su aplicación terapéutica
UA94603C2 (ru) Производные тетрагидронафталина, способ их получения и их применения в качестве ингибиторов воспаления
CR9058A (es) Derivados de indol como inhibidores de la adenilato ciclasa soluble
CR9391A (es) Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
UY29358A1 (es) Tiazolidinonas, su preparacion y su uso como medicamento
EA200700550A1 (ru) Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
UY30801A1 (es) Compuestos calciliticos
DE602007005387D1 (de) Ptors
CR9578A (es) Inhibidores de la adenilato ciclasa soluble

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)